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Cystic fibrosis transmembrane conductance regulator
(CFTR) regulates both HCO3
 secretion and HCO3
 sal-
vage in secretory epithelia. At least two luminal trans-
porters mediate HCO3
 salvage, the Na/H exchanger
(NHE3) and the Na-HCO3
 cotransport (NBC3). In a pre-
vious work, we show that CFTR interacts with NHE3 to
regulate its activity (Ahn, W., Kim, K. W., Lee, J. A., Kim,
J. Y., Choi, J. Y., Moe, O. M., Milgram, S. L., Muallem, S.,
and Lee, M. G. (2001) J. Biol. Chem. 276, 17236–17243). In
this work, we report that transient or stable expression
of human NBC3 (hNBC3) in HEK cells resulted in a Na-
dependent, DIDS (4,4-diisothiocyanostilbene-2,2-disul-
fonic acid)- and 5-ethylisopropylamiloride-insensitive
HCO3
 transport. Stimulation of CFTR with forskolin
markedly inhibited NBC3 activity. This inhibition was
prevented by the inhibition of protein kinase A. NBC3
and CFTR could be reciprocally coimmunoprecipitated
from transfected HEK cells and from the native pan-
creas and submandibular and parotid glands. Precipita-
tion of NBC3 or CFTR from transfected HEK293 cells
and from the pancreas and submandibular gland also
coimmunoprecipitated EBP50. Glutathione S-transfer-
ase-EBP50 pulled down CFTR and hNBC3 from cell ly-
sates when expressed individually and as a complex
when expressed together. Notably, the deletion of the
C-terminal PDZ binding motifs of CFTR or hNBC3 pre-
vented coimmunoprecipitation of the proteins and inhi-
bition of hNBC3 activity by CFTR. We conclude that
CFTR and NBC3 reside in the same HCO3
-transporting
complex with the aid of PDZ domain-containing scaf-
folds, and this interaction is essential for regulation of
NBC3 activity by CFTR. Furthermore, these findings
add additional evidence for the suggestion that CFTR
regulates the overall trans-cellular HCO3
 transport by
regulating the activity of all luminal HCO3
 secretion
and salvage mechanisms of secretory epithelial cells.
HCO3
 concentration is tightly controlled in all biological
fluids including fluids secreted by exocrine glands. The ductal
systems or their equivalents are the sites of active regulation of
HCO3
 content of the secreted fluids. This is also the site of
expression of the cystic fibrosis transmembrane conductance
regulator (CFTR)1 (1–5). The transporters participating in duc-
tal HCO3
 homeostasis and their regulation are only partially
known. Probably, the best results are available in the salivary
glands and pancreatic ducts. Active regulation of luminal
HCO3
 concentration and pHi requires the regulation of
both HCO3
 secretory and absorptive mechanisms. HCO3
 se-
cretion is believed to occur by HCO3
 influx across the basolat-
eral membrane mediated by a Na-HCO3
 cotransport mecha-
nism (6, 7). The transporter mediating this activity is probably
pNBC1, the pancreatic isoform of the electrogenic Na-HCO3

cotransporter family (8, 9). HCO3
 efflux across the luminal
membrane (LM) requires the activity of a Cl/HCO3
 exchange
mechanism (6, 10, 11) and is dependent on the expression of
CFTR both in human and in animal models (11, 12).
In the resting state, secretory glands have to absorb HCO3
.
The transporters involved in HCO3
 absorption are only begin-
ning to emerge. HCO3
 influx across the LM is in part the result
of Na/H exchange mediated by NHE3 (13, 14). However, in
recent studies with the pancreatic (13) and the submandibular
gland (SMG) ducts (9), we showed that50% HCO3
 absorption
(H secretion) is mediated by more than one Na-dependent
mechanism that is different from any known NHE isoform.
Furthermore, we found that the SMG duct and acinar cells
express several splice variants of NBC3 (rat orthologues
NBCn1B-D) and used anti-NBC3 antibodies to localize the
proteins to the LM (9). Using the perfused duct, we found
DIDS-insensitive Na-dependent HCO3
 transport activity in
the LM of the SMG duct and proposed that one or a combina-
tion of the NBC3 splice variants found in this tissue may
mediate this activity (9).
The regulation of HCO3
 transport at rest and the stimulated
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fibrosis (12, 15). It is of note that the C terminus of all the
HCO3
 transporters expressed in the LM including CFTR (16),
NHE3 (17), hNBC3 (19), and its rat orthologues NBCn1B-D
(electroneutral NBC splice variants) (18) end with a PDZ bind-
ing motif (DTRL, STHM, and ETSL, respectively). This finding
raised the possibility that all of the proteins form a HCO3

transport complex held together by scaffold proteins such as
EBP50 or PDZK1. CFTR in the complex may serve as a
“HCO3
 sensor” to regulate the activity of the other transport-
ers. Such an arrangement is supported by the tight binding of
CFTR (20) and the possible binding of NHE3 (17) to EBP50 and
CFTR to PDZK1 (21). In addition, the stimulation of CFTR
with protein kinase A inhibited NHE3 activity, and this inhi-
bition required the PDZ binding motif of CFTR (22). These
findings prompted us to test the regulatory interaction between
CFTR and NBC3. We report here that the expression of hNBC3
in HEK293 cells resulted in a DIDS- and EIPA-insensitive,
Na-dependent HCO3
 transport. When expressed in the same
cells, the stimulation of CFTR inhibited Na-HCO3
 cotrans-
port by hNBC3. Coimmunoprecipitation (Co-IP) and pull-down
assays indicate that the two proteins interact with each other
with the aid of PDZ scaffolds. Co-IP and inhibition of hNBC3
activity by CFTR required an intact PDZ binding motif in both
proteins. We propose that activated CFTR inhibits NBC3 ac-
tivity by mutual binding to a scaffolding protein containing
PDZ binding domains. In this manner, CFTR is able to regulate
another portion of the HCO3
 secretory/absorptive function of
secretory epithelia.
EXPERIMENTAL PROCEDURES
Materials and Solutions—BCECF-AM (2,7-bis(2-carboxyethyl-5,6-
carboxyfluorescein acetoxymethyl ester), was purchased from Molecu-
lar Probes, Inc. (Eugene, OR). Anti-CFTR, clone M3A7, was purchased
from Upstate Biotechnology (Lake Placid, NY). A synthetic peptide
corresponding to amino acids 1197–1214 was used in rabbits to gener-
ate a polyclonal antibody specific for human NBC3 (19). Goat anti-
rabbit or anti-mouse antibodies (Jackson Laboratories) were used as
the secondary antibodies at a 1:1000 dilution to probe the blots. Cell
culture reagents including LipofectAMINE were obtained from Invitro-
gen. The standard perfusion solution (solution A) contained 145 mM
NaCl, 1 mM MgCl2, 1 mM CaCl2, 10 mM HEPES (pH 7.4 with NaOH),
and 10 mM glucose. Na-free solutions were prepared by replacing Na
with N-methyl-D-glucamine. HCO3
-buffered solutions were prepared
by replacing 25 mM NaCl or N-methyl-D-glucamine-Cl with 25 mM
NaHCO3 or choline-HCO3, respectively, and reducing HEPES to 5 mM.
HCO3
-buffered solutions were gassed with 5% CO2, 95% O2. The osmo-
larity of all solutions was adjusted to 310 mosmol with the major salt.
Site-directed Mutagenesis—The QuikChange site-directed mutagen-
esis kit from Stratagene (La Jolla, CA) was used to generate the C-
hNBC3 (ESTL). The mutagenesis primers were as follows: antisense
5-GGT TCA ATT CTA TAA TGA AGT TTA AGC ATC CAC GTA TTT
C-3; sense 5-GAA ATA CGT GGA TGC TTA AAC TTC ATT ATA GAA
TTG AAC C-3; and sequencing primer 5-CGG GAC GTG AAC ACC
AAT ATA TAC-3. Oligonucleotide-directed mutagenesis using the
GeneEditor mutagenesis kit (Promega, Madison, WI) was performed in
the CFTR expression vector pCMVNot6.2 to delete the C-terminal 4
(DTRL) amino acids. The mutagenesis primer was as follows: 5-GGA
GAC AGA AGA AGA GGT GTA AGA TAC AAG GCT TTA GAG AG-3.
Incorporation of all mutations was verified by DNA sequencing.
Transient and Stable Expression in HEK293 Cells—Transient gene
transfer was accomplished using LipofectAMINE according to instruc-
tions provided by the manufacturer. Stable transfectants of hNBC3 and
C-hNBC3 were selected by G418 resistance (800 g/ml) conferred by a
neoR gene in the parent vector. After clonal selection by limited dilu-
tion, stable transfectants were maintained in normal growth medium
supplemented with 400 g/ml G418.
Animals and Tissue Preparations—Animals were allowed free access
to food and water and were studied at 1–2 months of age. Animals were
sacrificed by cervical dislocation after ether anesthesia. To harvest the
SMG, pancreas, and liver tissues, mice and rats were killed, the abdo-
men was opened, and the tissues were removed into a dish containing
ice-cold high K solution composed of 140 mM KCl, 10 mM HEPES, and
1 mM EDTA with pH 7.0 adjusted with KOH. The tissues were minced
into a fine paste and homogenized by 25 strokes at 1000 rpm with a
motor-driven glass-in-Teflon Potter homogenizer. The crude homoge-
nates were centrifuged at 100,000  g for 15 min, and the pellets were
resuspended in high K buffer and immediately used to prepare extract
by mixing with a 2 lysis buffer.
Immunoprecipitation and Immunoblotting—These procedures were
as described previously (22). Mice, rats, or HEK293 cell lysates (always
400 g of protein) were mixed with the appropriate antibodies and
incubated overnight at 4 °C in lysis buffer. Immune complexes were
collected by binding to protein G- or protein A-Sepharose and washing
four times with lysis buffer. The immunoprecipitates or lysates (always
40 g of protein) were suspended in SDS sample buffer and separated
by SDS-PAGE electrophoresis. The proteins were detected by incuba-
tions with the appropriate primary and secondary antibodies. The anti-
hNBC3 antibody was diluted 1:1000 in Tris-buffered saline (20 mM
TrisHCl, pH 7.5, and 137 NaCl), and monoclonal anti-CFTR antibodies
were diluted 1:500.
Pull-down Assay—For pull-down experiments, GST-EBP50 was
cloned in the pGEX vector and expressed in Escherichia coli (Amersham
Biosciences GST purification protocol). The vector was used to produce
GST alone for the control experiments. Isopropyl-1-thio--D-galactopy-
ranoside was used to induce gene expression. The bacteria were dis-
rupted using a combination of freeze-thaw and sonication. The lysate
was centrifuged at 18,000  g for 20 min at 4 °C. The supernatant was
dialyzed for 24 h at 4 °C against PBS and incubated with 2 ml of
glutathione-Sepharose 4B for 4 h at 4 °C with gentle agitation. The
Sepharose beads were washed with 200 ml of PBS, and GST-EBP50 and
GST proteins were eluted using glutathione elution buffer and dialyzed
against PBS. The proteins were quantitated using SDS-PAGE following
by Coomassie Blue staining and Western blotting. 100 g of GST-
EBP50 or GST in 0.5 ml of PBS were mixed with 0.5-ml extracts
containing 400 g of protein prepared from HEK293 cells expressing
CFTR, hNBC3, C-hNBC3, CFTRhNBC3, or C-CFTRhNBC3. Af-
ter incubation for 10 h at 4 °C, the solution was mixed with 25 l of
glutathione-Sepharose 4B, incubated for 4 h at 4 °C with gentle agita-
tion, washed 10 times with 1 ml of PBS, eluted with glutathione elution
buffer, and analyzed using SDS-PAGE and Western blotting. Primary
mouse anti-human CFTR antibody (RDI, Flanders, NJ) was used at a
dilution 1:2000, and rabbit anti-hNBC3 antibody (C1) was used at a
dilution 1:1000. Secondary horseradish peroxidase-conjugated anti-
mouse and anti-rabbit antibodies were used at a dilution of 1:20,000.
Intracellular pH Measurement—For the measurement of pHi in
transfected HEK293 cells, glass coverslips with cells attached to them
were washed once with solution A and assembled to form the bottom of
a perfusion chamber. The cells were loaded with BCECF by a 10-min
incubation at room temperature in solution A containing 2.5 M
BCECF-AM, and dye loading was monitored. After dye loading, the cells
were perfused with appropriate solutions and pHi was measured by
photon counting using a fluorescence measuring system (Delta Ram,
PTI Inc., South Brunswick, NJ). In the case of hNBC3, CFTR or their
C-terminal deleted mutants, a GFP-expressing plasmid (Invitrogen),
was cotransfected with the constructs, and pHi measurements were
performed with cells expressing GFP. The bath was perfused at a flow
rate of 6 ml/min using the desired solutions that were maintained at
37 °C. The fluorescence ratios of 490/440 nm were calibrated by perfus-
ing the cells with solutions containing 145 mM KCl, 10 mM HEPES, and
5 M nigericin.
Statistical Analysis—Values are expressed as the means  S.E. The
significance of differences between mean values was examined using
ANOVA. p  0.05 was considered statistically significant.
RESULTS AND DISCUSSION
Properties of hNBC3 Expressed in HEK293 Cells—At least
two HCO3
 salvage mechanisms have been identified in the LM
of the ducts of the secretory glands SMG (9) and pancreas (13)
and NHE3 and splice variants of NBC3. Because this mem-
brane expresses CFTR and the scaffold EBP50 (22) and be-
cause all of the proteins have a PDZ binding motif in their C
terminus, we proposed that CFTR could regulate the overall
process of luminal HCO3
 transport. When stimulated by pro-
tein kinase A, CFTR can activate HCO3
 secretion and in the
same time it can inhibit HCO3
 salvage that take place in the
resting state (9, 11, 13). To test this hypothesis, we showed that
stimulation of CFTR expressed in heterologous systems (23)
and in the native SMG and the pancreatic ducts (11) activates
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Cl/HCO3
 exchange. Activation of CFTR also inhibited NHE3
activity both in the native pancreatic duct and in heterologous
systems (22).
In this work, we continued testing this hypothesis by study-
ing the regulatory interaction between CFTR and NBC3. For
this reason, we expressed hNBC3 in HEK293 cells and char-
acterized its activity. hNBC3 and the C-hNBC3 from which
the last four-amino acid PDZ binding motif was truncated were
expressed either transiently or by isolating stable cell lines
expressing the proteins (see “Experimental Procedures”). Sim-
ilar results were obtained with both methods (data not shown),
and thus, the results from both sets of experiments were com-
bined. Fig. 1 shows the basic experimental protocol used to
follow NBC activity. Cells were incubated for 90–120 min in a
K-free solution containing 0.1 mM ouabain to load them with
Na. The cells were maintained in this solution during dye
loading and were perfused throughout with K-free solutions
to keep the Na pump inhibited. For controls, HEK293 cells
were transfected with GFP only and were equilibrated with a
HCO3
-buffered solution. The cells were incubated with 2.5–10
M EIPA to inhibit all NHE activity and then were exposed
consecutively to a Na-free and Na-containing solutions. This
resulted in slow rates of cytoplasmic acidification and alkalin-
ization, respectively (Fig. 1A), probably because of low endog-
enous NBC activity (see below). The low NBC activity of this
HEK293 clone was suitable for characterizing the activity of
the expressed proteins.
Fig. 1B shows the activity observed in cells transfected
with GFP and hNBC3. Exposing Na-loaded cells incubated
in HEPES-buffered solution containing 10 M EIPA to a
Na-free solution had no apparent effect on pHi. This was
somewhat unexpected because the expression of hNBC3 in
Xenopus oocytes showed that hNBC3 could transport both
OH and HCO3
 (19). The difference can be attributed to
differential behavior of hNBC3 in the mammalian HEK293
cells and in Xenopus oocytes. Alternatively, because hNBC3
transports HCO3
 better than OH, it is possible that the
expression levels in HEK293 cells did not reach those in
Xenopus oocytes and thus did not allow us to see the OH
transport by hNBC3. In this respect, hNBC3 expressed in
HEK293 cells behaved like its rat orthologue NBCn1B ex-
pressed in Xenopus oocytes (18) in that both showed no Na-
OH cotransport.
After equilibration in a HCO3
-buffered medium that also
contained 10 M EIPA, exposing cells expressing hNBC3 to a
Na-free medium resulted in rapid cytosolic acidification that
was reversed upon re-addition of Na to the perfusion solution
(Fig. 1B). Similar to all other cells, HEK293 cells express NHE
activity that was almost completely inhibited by 0.5 M EIPA,
indicative of NHE1 activity. This is shown in Fig. 2B for cells
expressing hNBC3, and similar results were obtained in con-
trol cells and cells expressing C-hNBC3. In multiple experi-
ments (at least three at each concentration), EIPA between 0.5
and 100 M did not inhibit the Na-dependent changes in pHi
illustrated in Fig. 1, B and C, that were measured in the
presence of HCO3
 in cells expressing hNBC3 or C-hNBC3.
Hence, again, it seems that hNBC3 behaves differently when
expressed in Xenopus oocytes and HEK293 cells, because
hNBC3 activity was inhibited by 100 M EIPA in Xenopus
oocytes (19). The activity of NBCn1B expressed in Xenopus
FIG. 1. Measurement of Na-HCO3
 cotransport in HEK293
cells transfected with hNBC3. Cells transfected with GFP (A),
hNBC3 (B), or C-hNBC3 (C) were incubated in a K-free solution
containing 0.1 mM ouabain for 90–120 min before assembly into the
perfusion chamber. The cells were perfused with K-free solutions
throughout. An open bar indicates perfusion with HEPES-buffered
solutions, and a gray bar indicates perfusion with HCO3
-buffered so-
lutions. The periods of incubation with Na-free solutions are marked
by dotted arrows. The cells were incubated with 10 M EIPA as indi-
cated by the solid lines. Note that expression of NBC3 resulted in a
Na-dependent EIPA-insensitive HCO3
 efflux and influx activity. The
models depict the direction of Na-HCO3
 cotransport.
FIG. 2. Na-HCO3
 cotransport by hNBC3 is resistant to DIDS
and EIPA. Cells transfected with GFP (A) or hNBC3 (B and C) were
equilibrated with HCO3
 (A and C) or HEPES-buffered solutions (B). A
and C, the solution also contained 2.5 M EIPA. The cells were exposed
to Na-free solutions to estimate NHE (B) or NBC (A and C) activity
before (control period) and after treatment with DIDS. The cells A and
C were treated with 0.5 mM DIDS where indicated by the solid bar. The
cells in B were treated with EIPA as indicated.
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oocytes was not inhibited by EIPA (18). Finally, Fig. 1C shows
that ChNBC3 behaved similarly to hNBC3. The rates of Na-
dependent HCO3
 influx in acidified cells were 0.67  0.08 (n 	
17) and 0.71  0.07 (n 	 6) pH units/min in cells transfected
with hNBC3 and ChNBC3, respectively. Therefore, the dele-
tion of the PDZ binding motif of hNBC3 does not affect expres-
sion, processing, or activity of the protein.
A feature distinguishing Na-HCO3
 cotransport by hNBC3
(19) and its rat orthologues (18) from that by the electrogenic
family of NBCs is the insensitivity of the transport to DIDS,
because the electroneutral NBCs do not have a canonical DIDS
binding motif (18, 19). Therefore, we measured the effect of
DIDS on the activity of hNBC3 expressed in HEK293 cells. Fig.
2A shows that non-transfected HEK293 cells have small NBC
activity, which was largely inhibited by pre-incubating the cells
with 0.5 mM DIDS. Fig. 2C shows that pre-incubation of acid-
ified cells expressing hNBC3 with 0.5 mM DIDS inhibited Na-
dependent HCO3 influx by only 26  5% (n 	 4), which can be
attributed to the endogenous DIDS-sensitive NBC activity il-
lustrated in Fig. 2A.
Interaction between hNBC3 and CFTR—Based on the com-
bined results in Figs. 1 and 2, we can conclude that the expres-
sion of the hNBC3 clone in HEK293 cells resulted in the ap-
pearance of a DIDS- and EIPA-insensitive Na-HCO3

cotransport activity. In addition, the hNBC3 expressed in
HEK293 cells could be detected readily by Western blot using
specific anti-hNBC3 antibodies (19). This is illustrated in Fig.
3A, upper panel. In all of the experiments tested (10), non-
transfected HEK293 cells or HEK293 cells transfected with
GFP showed low expression level of hNBC3. The expression of
hNBC3 or C-hNBC3 increased the protein level detected by
the anti-hNBC3 antibodies 
7-fold. As was found for the ac-
tivity, there was no discernable difference in the expression of
hNBC3 and C-hNBC3. The agreement between protein ex-
pression and activity of the hNBC3 clones indicates that indeed
the activity measured in Figs. 1 and 2 is attributed to the
expressed clones, and the expressed clones can be used to study
interaction with CFTR.
As indicated above, CFTR and hNBC3 have the PDZ binding
motif in their C terminus. To determine whether the two pro-
teins interact with each other and the importance of the PDZ
binding motifs for this interaction, we prepared clones for the
expression of CFTR, C-CFTR, hNBC3, and C-hNBC3 and
tested the interaction between the proteins by Co-IP. First, we
found that the expression of WT-CFTR or C-CFTR did not
affect expression of any of the hNBC3 clones (Fig. 3A, upper
blot). We then immunoprecipitated CFTR and probed for
hNBC3. Fig. 3A, middle blot, shows that a similar amount of
CFTR was immunoprecipitated from all of the cells. Fig. 3A,
bottom blot, shows that hNBC3 can be coimmunoprecipitated
with CFTR and that the deletion of the PDZ binding motifs of
CFTR or of hNBC3 markedly reduced Co-IP of hNBC3. A small
FIG. 4. Co-IP of EBP50, CFTR, and NBC3 and pull down of
CFTR and hNBC3 by GST-EBP50. Panel A, extracts (40 g of pro-
tein) from HEK293 cells transfected with hNBC3, C-hNBC3,
hNBC3CFTR, and C-hNBC3C-CFTR were used to estimate ex-
pression of EBP50 in HEK293 cells (upper blot). Cells were also trans-
fected with EBP50 to positively identify the protein (right-most lane in
upper blot). The extracts (400 g of protein) were also used to immu-
noprecipitate CFTR (IP: CFTR) and blot for EBP50 (Blot: EBP50) and
hNBC3 (Blot: hNBC3). WB, Western blot. Panels B–E, recombinant
GST-EBP50 (B and D) or GST alone (control) (C and E) bound to beads
was used to pull down CFTR and hNBC3 from 400-g protein of
extracts prepared from non-transfected cells or cells transfected with
CFTR, hNBC3, C-hNBC3, C-CFTR, or a combination of the proteins.
The blots in B and C were probed for hNBC3, and the blots in D and E
were probed for CFTR.
FIG. 3. Co-IP of CFTR and NBC3 expressed in HEK cells. Panel
A, extracts were prepared from control cells (HEK-Con) and cells stably
expressing hNBC3 or C-hNBC3 and transfected with WT-CFTR or
C-CFTR. The cells were used to assay the effect of expression of the
CFTR constructs on the expression of NBC3 by Western blot (upper
blot, 40 g in each lane) and for immunoprecipitation (IP, 400-g
extract at each condition) of CFTR. The immunoprecipitates were an-
alyzed for CFTR (middle blot) and hNBC3 (lower blot). Panel B, 400 g
of extracts from control cells and cells transfected with CFTR only.
hNBC3CFTR or hNBC3C-CFTR were used to immunoprecipitate
hNBC3 and blot for hNBC3 (upper blot) or CFTR (lower blot).
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amount of hNBC3 sometimes coimmunoprecipitated with C-
CFTR, and a small amount of C-hNBC3 sometimes coimmu-
noprecipitated with WT-CFTR. This small amount of Co-IP
probably represents nonspecific binding of the NBC3s to the
beads because it was not observed in all experiments (see Fig.
4A). The reciprocal experiment is shown in Fig. 3B. Immuno-
precipitation of hNBC3 from cells expressing hNBC3 and WT-
CFTR coimmunoprecipitated WT-CFTR. This Co-IP was mark-
edly lower in cells expressing hNBC3 and C-CFTR. Fig. 3B
shows that a similar amount of CFTR was coimmunoprecipi-
tated by the anti-hNBC3 antibodies from cells expressing only
WT-CFTR and cells expressing hNBC3 and C-CFTR.
The results in Fig. 3 clearly show that CFTR interacts with
hNBC3 and that the interaction requires the PDZ binding
motif of both proteins. Potential scaffolding proteins that me-
diate the interaction between CFTR and hNBC3 are EBP50
and PDZK1, because both scaffolds bind CFTR (20, 21). Pre-
liminary results showed that HEK293 cells express EBP50;
therefore, we tested whether immunoprecipitation (IP) of
CFTR can coimmunoprecipitate both hNBC3 and EBP50. The
results are shown in Fig. 4A. EBP50 was positively identified
by expressing the protein in HEK293 cells (Fig. 4A, right lane
in upper blot). IP of CFTR coimmunoprecipitated EBP50 and
hNBC3, and the Co-IP was abolished when C-hNBC3 was
expressed with WT-CFTR. To obtain further evidence for the
role of scaffolds like EBP50 in mediating the interaction be-
tween the transporters, the proteins were expressed in
HEK293 cells and recombinant-purified GST-EBP50 was used
for a pull-down assay. Fig. 4, B and C, show that GST-EBP50
pulled down CFTR and hNBC3 when expressed individually in
HEK293 cells (first two lanes in each blot). Importantly, GST-
EBP50 pulled the two proteins when expressed together (last
lane in each blot).
The results in Figs. 3 and 4 suggest that CFTR interacts with
hNBC3, and the interaction is mediated by scaffolding proteins
with PDZ domains similar to those of EBP50. These results
were obtained in expression systems. It is essential to deter-
mine whether such interaction between the proteins occurs in
vivo. To test this, we attempted to coimmunoprecipitate CFTR
and NBC3 from the rat SMG and parotid glands and the mouse
pancreas and SMG. These secretory glands were selected be-
cause they express high levels of CFTR (1). The SMG duct and
acinar cells express several splice variants of NBCn1 (9), and
RT-PCR analysis showed similar expression of NBCn1 splice
variants in the pancreas.2 Fig. 5A, upper blot, shows that
immunoprecipitation of rat NBC3 coimmunoprecipitates
CFTR, and Fig. 5A, lower blot, shows that immunoprecipitation
of rat CFTR coimmunoprecipitates NBC3. Similarly, Fig. 5B
shows the reciprocal Co-IP of the proteins from the mouse
pancreas and SMG. Interestingly, immunoprecipitation of
CFTR or NBC3 coimmunoprecipitated EBP50 from the pan-
creas and SMG, indicating that both proteins may interact in
vivo with the PDZ binding domain(s) of EBP50. Little or no
signal was observed with liver extract, probably because CFTR
is expressed only in bile ducts and the majority of the mem-
branes are from hepatocytes. At any rate, liver extracts serve
as a good negative control for the coimmunoprecipitate ob-
served with pancreatic and SMG extracts.
The interaction between NBC3 and CFTR in vivo and in
2 X. Luo and S. Muallem, unpublished observation.
FIG. 5. Co-IP of CFTR and NBC3 expressed in native tissues. A,
extracts were prepared from rat SMG or parotid (Par) glands, and 400
g were used for IP of NBC3 (IP-NBC3) and blotting for CFTR (WB-
CFTR) or IP of CFTR (IP-CFTR) and blotting for NBC3 (WB-NBC3).
For controls (Con), SMG extract was used, and the primary antibodies
used for the IP were omitted. B, Co-IP of CFTR, NBC3, and EBP50
using 400 g from the mouse liver (Liv), pancreas (Pan), and SMG. A
mixture of primary antibodies and extract from liver (first lane in each
blot) was used as a control. Note that IP of CFTR coimmunoprecipitates
NBC3 and EBP50, and IP of NBC3 coimmunoprecipitates CFTR and
EBP50.
FIG. 6. Effect of CFTR on hNBC3 activity. HEK293 cells stably or
transiently expressing hNBC3 or C-hNBC3 were transfected with
CFTR or C-CFTR. The cells were loaded with Na by incubation in
K-free medium containing ouabain, equilibrated in a HCO3
-buffered
medium, and incubated in Na-free medium to acidify the cytosol to pHi
of
6.5. Near the end of the acidification, the cells were stimulated with
5 M forskolin and treated with 10 M EIPA while still in Na-free
medium. In B, the cells transfected with hNBC3 and hNBC3CFTR
(dotted lines) were also treated with 10 M H89 after cell acidification.
Na-HCO3
 cotransport was then initiated by exposing the cells to a
solution containing forskolin, EIPA, and 140 mM Na. A and B show
individual examples under each condition, and C summarizes the re-
sults of 3–9 experiments. Note that the activation of CFTR inhibited
hNBC3 activity, which was largely prevented by inhibition of protein
kinase A with H89, and that deletion of the PDZ binding motifs of CFTR
or hNBC3 prevented the inhibition. NS, not significant.
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heterologous systems raised the possibility that CFTR regu-
lates NBC3 activity in a manner similar to the regulation of
NHE3 activity by CFTR (22). To test this possibility, hNBC3
and C-hNBC3 were coexpressed with CFTR or C-CFTR, and
NBC activity was measured. Figs. 6, A and B, show individual
experiments, and Fig. 6C summarizes the results of 3–9 exper-
iments under each condition. To compare NBC activity under
the same conditions, all cells were loaded with Na and equil-
ibrated in a HCO3
-buffered medium and then were incubated
in a HCO3
-buffered Na-free medium to deplete the cells of
Na and acidify the cytosol (including the cytosol of control
cells transfected with GFP). When pHi was close to 6.5, all cells
were stimulated with forskolin to activate CFTR and incubated
with 10 M EIPA to inhibit the NBC-independent mechanisms.
In separate control experiments, we found that unstimulated
CFTR had no effect on hNBC3 activity (data not shown), con-
firming the Western blot data in Fig. 3A, which show that the
expression of CFTR had no effect on expression of hNBC3.
Na-HCO3
 cotransport activity was initiated by perfusing the
cells with medium containing forskolin, EIPA, and 140 mM
Na. The expression of CFTR or C-CFTR alone had minimal
effect on the rate of alkalinization (Fig. 6, A and B), although
CFTR activates Cl and HCO3
 transport (13, 15). This is
probably because Cl and HCO3
 transport is very low at pHi of
6.5 at which internal [HCO3
] is very low. However, stimulated
WT-CFTR inhibited hNBC3 activity by 
67  11% (n 	 7, p 
0.01) (Fig. 6, A and C). Notably, C-CFTR had no effect on
hNBC3 activity, and WT-CFTR had no effect on the activity of
C-hNBC3 (Figs. 6, B and C). Finally, to further show that
activation of CFTR was required for inhibition of hNBC3, we
tested the effect of the protein kinase A inhibitor H89. H89
alone slightly inhibited the activity of hNBC3. The mechanism
and significance of this inhibition were not investigated here.
Significantly, treatment with H89 prevented inhibition of
hNBC3 activity by stimulated CFTR (Fig. 6, B and C). Hence,
activated CFTR inhibits hNBC3 activity, and this inhibition
required the interaction among the proteins that is mediated
by their PDZ binding motifs.
In summary, in this work, we provide biochemical and func-
tional evidence for regulatory interaction between CFTR and
hNBC3. This interaction required the PDZ binding motifs of
both proteins, suggesting that the interaction is indirect and is
probably mediated by scaffolding protein such as EBP50 or
PDZK1. The consequence of this interaction is the ability of
activated CFTR to inhibit the activity of hNBC3. Importantly,
not only are CFTR and NBC3 expressed in the LM of secretory
cells (1, 9, 24), they could be coimmunoprecipitated (Fig. 5),
indicating that the two proteins also interact in vivo. The
regulation of NBC3 activity by CFTR lend further support to
the idea that CFTR regulates the entire process of HCO3

transport across the LM of secretory epithelial cells. Thus,
activated CFTR dramatically activates Cl and HCO3
 trans-
port (11, 15, 23) and at the same time inhibits HCO3
 salvage by
NHE3 (13) and NBC3 (this work). Two obvious questions are
how CFTR can regulate so many transporters and transport
functions and how EBP50, which has only two PDZ domains,
can mediate so many interactions? CFTR is probably a central
member of a protein complex in the luminal membrane of
secretory epithelial cells. The scaffolding protein(s) assembling
the complex is not known with certainty. Secretory cells ex-
press more than one scaffolding protein in their luminal pole
that can bind CFTR. Furthermore, the complex probably con-
tains more than one scaffolding protein, similar to other multi-
proteins complexes as found in the postsynaptic density (24)
and in caveolae (25). Thus, at present, it is not clear how the
HCO3
 transport complex is assembled and whether CFTR and
NBC3 bind to the same scaffold. Nonetheless, their ability to
bind to PDZ binding domains is one mechanism by which CFTR
can function as a HCO3
 sensor governing the activity of the
HCO3
-transporting complex.
Interestingly, in a previous work (9), we showed that both
SMG acinar and duct cells express NBC3, although the two cell
types express different splice variants of the protein. In addi-
tion, localization of NBC3 isoforms is cell-specific. NBC3 splice
variants were localized to the luminal membrane of SMG cells
(9) intercalated cells, and the cortical-collecting duct (26–28)
but to the basolateral membrane of the thick ascending limb
(25) and duodenal enterocytes (29). If the activity of NBC3 is
regulated in all cells and in all membranes by regulatory in-
teraction with other proteins, it is possible that other ABC
transporters or proteins that interact with the scaffold(s),
which binds NBC3, can regulate the activity of NBC3 in a
manner similar to that of CFTR described here. Hence, it will
be of interest in the future to examine the regulation of NBC3
and other HCO3
 transporters with PDZ binding motifs by
members of the ABC transporters family. Such a regulation
may be a general mechanism for the regulation of cellular
HCO3
 transport.
The physiological significance of the findings in this work
remains to be fully established because of the insensitivity of
hNBC3 activity to inhibition by EIPA. Although NBC3 is ex-
pressed in the luminal membrane of secretory ducts (9), the
activity found in the duct is DIDS-insensitive but EIPA-sensi-
tive. However, the cells express more than one splice variant of
NBC3. This finding raises the possibility that the splice vari-
ants interact with each other to mediate NBC3 activity. Thus,
it is possible that substrate specificity and sensitivity to block-
ers are functions of the exact splice variants expressed in a cell
type and the interaction between them. Indeed, SMG acinar
and duct cells express different NBC3 splice variants. The
transporters in acinar cells transport HCO3
 but not OH,
whereas the transporters in the duct transport both HCO3
 and
OH. An analysis of the behavior of all splices variants and the
relationship between them is required to fully address this
problem. Nevertheless (a) the expression of NBC3 and CFTR in
the luminal membrane HCO3
-transporting complex, their PDZ
domain-mediated interaction, and inhibition of NBC3 activity
by stimulated CFTR suggests that NBC3 plays a major role in
HCO3
 salvage. In this manner, CFTR regulates this process by
regulating the activity of both NHE3 and NBC3.
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